Game-changing news for life-saving research: $59 million grant fuels biotherapeutics expansion at The Ottawa Hospital’s new campus
May 6, 2024
The Ottawa Hospital will become part of a nation-wide network for biotherapeutics research with the May 6th announcement that TOH will be receiving $59 million to expand our Biotherapeutics Manufacturing Centre to our new campus.
This investment will boost our local capacity, as well as capacity across Canada, to develop and manufacture life-saving biotherapeutics, including vaccines, gene therapies and cell therapies.
Read more about how this will enhance treatment options and outcomes for patients.